ProEthic Pharmaceuticals clinical trials

Acquired by Kowa Company, Ltd.

The registry lists 1 studies whose lead sponsor is ProEthic Pharmaceuticals. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 2, 2007.

Status

Completed: 1

Phase

Phase 3: 1

Where

United States: 1

Registry sponsor names on this page

ProEthic Pharmaceuticals1 study

Something wrong with this grouping? Tell us on the Kowa Company, Ltd. page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Kowa Company, Ltd. studies →

An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine AttackCompletedNCT00330850Phase 3
Sponsor listed in the registry: ProEthic Pharmaceuticals · ProEthic Pharmaceuticals — acquired company within the Kowa Company, Ltd. group